CNTX position history
The shares of Context Therapeutics (CNTX) that Avidity Partners Management LP reported in each quarter’s 13F.
Shares held by quarter
New Add Reduce Exit
- 2024 Q2: 7,419,355 shares, $15M, 0.63% of portfolio, New
- 2024 Q3: 7,417,155 shares, $15M, 0.74% of portfolio, Reduce 0.0%
- 2024 Q4: 7,477,200 shares, $7.9M, 0.77% of portfolio, Add +0.8%
- 2025 Q1: 7,477,200 shares, $4.6M, 0.87% of portfolio
- 2025 Q2: 7,477,255 shares, $4.9M, 0.98% of portfolio, Add 0.0%
- 2025 Q3: 8,981,855 shares, $8.7M, 2.0% of portfolio, Add +20.1%
- 2025 Q4: 5,504,855 shares, $8.1M, 2.3% of portfolio, Reduce −38.7%
- 2026 Q1: 9,996,534 shares, $25M, 2.7% of portfolio, Add +81.6%
- 2026 Q2: 4,998,267 shares, $2.8M, 0.44% of portfolio, Reduce −50.0%
| Holdings date | Value | % of holdings | Shares | Filing date | All 13F holders |
|---|